WEDNESDAY, July 16, 2025 (HealthDay News) — GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all. But that’s a false notion, experts say. Losing weight properly and keeping it off will require lifestyle changes thatContinue Reading
MONDAY, July 14, 2025 (HealthDay News) — Cancer deaths linked to obesity more than tripled in the U.S. during the past two decades, a new study says. Deaths linked to the 13 types of obesity-related cancer rose to 13.5 deaths per million from 3.7 deaths per million between 1999 andContinue Reading
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulantsContinue Reading
FRIDAY, June 27, 2025 (HealthDay News) — A person’s body fat percentage provides a better estimate of their risk for early death than their body mass index (BMI), a new study says. People with a high body-fat percentage were 78% more likely to die within 15 years from any causeContinue Reading
WEDNESDAY, June 25, 2025 (HealthDay News) — Alternatives to weekly injections of weight-loss drugs may on the way. A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body weight over a year, researchers reported Monday in TheContinue Reading
WEDNESDAY, June 25, 2025 (HealthDay News) — Fitness trackers aren’t accurately assessing the physical activity of people with obesity, a new study argues. Differences in walking gait, speed, energy burn and other factors mean that folks with excess weight aren’t getting an accurate read from their devices, researchers wrote inContinue Reading
TUESDAY, June 24, 2025 (HealthDay News) — Weighted vests have been touted as a potential means of warding off osteoporosis while losing weight. The idea is that the extra weight will promote new bone growth even as people are walking or jogging to lose weight. But this idea isn’t backedContinue Reading
TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic/Wegovy and Zepbound, clinical trial results show. Ecnoglutide helped people lose between 9% to 13% of their body weight on average after 40 weeks of treatment, according toContinue Reading
MONDAY, June 23, 2025 (HealthDay News) — Want to lose weight and reverse type 2 diabetes? Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see their type 2 diabetes go into remission if they drankContinue Reading
SATURDAY, June 14, 2025 (HealthDay News) — Think you need to spend hours lifting weights to build muscle or get stronger? Researchers at Florida Atlantic University say just a few smart, focused sets may be all it takes this summer to see real gains. The study — available as aContinue Reading